Eagle Pharmaceuticals Inc (EGRX)
0.6501
-0.05
(-7.19%)
USD |
OTCM |
Nov 15, 10:00
Eagle Pharmaceuticals Total Return Level: 0.7005 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 0.7005 |
November 13, 2024 | 0.75 |
November 12, 2024 | 0.9001 |
November 11, 2024 | 0.85 |
November 08, 2024 | 0.851 |
November 07, 2024 | 0.85 |
November 06, 2024 | 0.80 |
November 05, 2024 | 0.80 |
November 04, 2024 | 0.50 |
November 01, 2024 | 0.55 |
October 31, 2024 | 0.60 |
October 30, 2024 | 0.50 |
October 29, 2024 | 0.40 |
October 28, 2024 | 0.35 |
October 25, 2024 | 0.60 |
October 24, 2024 | 0.65 |
October 23, 2024 | 0.64 |
October 22, 2024 | 0.70 |
October 21, 2024 | 0.70 |
October 18, 2024 | 0.90 |
October 17, 2024 | 0.65 |
October 16, 2024 | 0.80 |
October 15, 2024 | 0.60 |
October 14, 2024 | 0.60 |
October 11, 2024 | 0.875 |
Date | Value |
---|---|
October 10, 2024 | 0.60 |
October 09, 2024 | 0.93 |
October 08, 2024 | 0.55 |
October 07, 2024 | 0.65 |
October 04, 2024 | 0.8999 |
October 03, 2024 | 1.99 |
October 02, 2024 | 2.14 |
October 01, 2024 | 3.56 |
September 30, 2024 | 3.73 |
September 27, 2024 | 3.95 |
September 26, 2024 | 4.06 |
September 25, 2024 | 3.88 |
September 24, 2024 | 3.89 |
September 23, 2024 | 3.895 |
September 20, 2024 | 3.96 |
September 19, 2024 | 4.27 |
September 18, 2024 | 4.28 |
September 17, 2024 | 4.43 |
September 16, 2024 | 4.23 |
September 13, 2024 | 4.31 |
September 12, 2024 | 3.83 |
September 11, 2024 | 3.73 |
September 10, 2024 | 3.83 |
September 09, 2024 | 3.90 |
September 06, 2024 | 4.25 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.35
Minimum
Oct 28 2024
60.45
Maximum
Dec 17 2019
33.34
Average
40.69
Median
Jun 11 2021
Total Return Level Benchmarks
Eli Lilly and Co | 2270.02 |
Verrica Pharmaceuticals Inc | 0.8633 |
NovaBay Pharmaceuticals Inc | 0.727 |
Palatin Technologies Inc | 1.07 |
iBio Inc | 2.15 |